Parenteral Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1377718 | Published Date: Jan 2025 | No. of Page: 122 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Parenteral Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Parenteral Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Parenteral Drugs Overall Market Size
    2.1 Global Parenteral Drugs Market Size: 2021 VS 2028
    2.2 Global Parenteral Drugs Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Parenteral Drugs Sales: 2017-2028
3 Company Landscape
    3.1 Top Parenteral Drugs Players in Global Market
    3.2 Top Global Parenteral Drugs Companies Ranked by Revenue
    3.3 Global Parenteral Drugs Revenue by Companies
    3.4 Global Parenteral Drugs Sales by Companies
    3.5 Global Parenteral Drugs Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Parenteral Drugs Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Parenteral Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Parenteral Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Parenteral Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Parenteral Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Parenteral Drugs Market Size Markets, 2021 & 2028
        4.1.2 LVP Drug
        4.1.3 SVP Drug
    4.2 By Type - Global Parenteral Drugs Revenue & Forecasts
        4.2.1 By Type - Global Parenteral Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Parenteral Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Parenteral Drugs Revenue Market Share, 2017-2028
    4.3 By Type - Global Parenteral Drugs Sales & Forecasts
        4.3.1 By Type - Global Parenteral Drugs Sales, 2017-2022
        4.3.2 By Type - Global Parenteral Drugs Sales, 2023-2028
        4.3.3 By Type - Global Parenteral Drugs Sales Market Share, 2017-2028
    4.4 By Type - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Parenteral Drugs Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Medical Centers
        5.1.4 Others
    5.2 By Application - Global Parenteral Drugs Revenue & Forecasts
        5.2.1 By Application - Global Parenteral Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Parenteral Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Parenteral Drugs Revenue Market Share, 2017-2028
    5.3 By Application - Global Parenteral Drugs Sales & Forecasts
        5.3.1 By Application - Global Parenteral Drugs Sales, 2017-2022
        5.3.2 By Application - Global Parenteral Drugs Sales, 2023-2028
        5.3.3 By Application - Global Parenteral Drugs Sales Market Share, 2017-2028
    5.4 By Application - Global Parenteral Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Parenteral Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Parenteral Drugs Revenue & Forecasts
        6.2.1 By Region - Global Parenteral Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Parenteral Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Parenteral Drugs Revenue Market Share, 2017-2028
    6.3 By Region - Global Parenteral Drugs Sales & Forecasts
        6.3.1 By Region - Global Parenteral Drugs Sales, 2017-2022
        6.3.2 By Region - Global Parenteral Drugs Sales, 2023-2028
        6.3.3 By Region - Global Parenteral Drugs Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Parenteral Drugs Revenue, 2017-2028
        6.4.2 By Country - North America Parenteral Drugs Sales, 2017-2028
        6.4.3 US Parenteral Drugs Market Size, 2017-2028
        6.4.4 Canada Parenteral Drugs Market Size, 2017-2028
        6.4.5 Mexico Parenteral Drugs Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Parenteral Drugs Revenue, 2017-2028
        6.5.2 By Country - Europe Parenteral Drugs Sales, 2017-2028
        6.5.3 Germany Parenteral Drugs Market Size, 2017-2028
        6.5.4 France Parenteral Drugs Market Size, 2017-2028
        6.5.5 U.K. Parenteral Drugs Market Size, 2017-2028
        6.5.6 Italy Parenteral Drugs Market Size, 2017-2028
        6.5.7 Russia Parenteral Drugs Market Size, 2017-2028
        6.5.8 Nordic Countries Parenteral Drugs Market Size, 2017-2028
        6.5.9 Benelux Parenteral Drugs Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Parenteral Drugs Revenue, 2017-2028
        6.6.2 By Region - Asia Parenteral Drugs Sales, 2017-2028
        6.6.3 China Parenteral Drugs Market Size, 2017-2028
        6.6.4 Japan Parenteral Drugs Market Size, 2017-2028
        6.6.5 South Korea Parenteral Drugs Market Size, 2017-2028
        6.6.6 Southeast Asia Parenteral Drugs Market Size, 2017-2028
        6.6.7 India Parenteral Drugs Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Parenteral Drugs Revenue, 2017-2028
        6.7.2 By Country - South America Parenteral Drugs Sales, 2017-2028
        6.7.3 Brazil Parenteral Drugs Market Size, 2017-2028
        6.7.4 Argentina Parenteral Drugs Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Parenteral Drugs Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Parenteral Drugs Sales, 2017-2028
        6.8.3 Turkey Parenteral Drugs Market Size, 2017-2028
        6.8.4 Israel Parenteral Drugs Market Size, 2017-2028
        6.8.5 Saudi Arabia Parenteral Drugs Market Size, 2017-2028
        6.8.6 UAE Parenteral Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Ostuka Pharmaceutical
        7.1.1 Ostuka Pharmaceutical Corporate Summary
        7.1.2 Ostuka Pharmaceutical Business Overview
        7.1.3 Ostuka Pharmaceutical Parenteral Drugs Major Product Offerings
        7.1.4 Ostuka Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.1.5 Ostuka Pharmaceutical Key News
    7.2 Teva Pharmaceutical Industries
        7.2.1 Teva Pharmaceutical Industries Corporate Summary
        7.2.2 Teva Pharmaceutical Industries Business Overview
        7.2.3 Teva Pharmaceutical Industries Parenteral Drugs Major Product Offerings
        7.2.4 Teva Pharmaceutical Industries Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.2.5 Teva Pharmaceutical Industries Key News
    7.3 Kelun Pharma
        7.3.1 Kelun Pharma Corporate Summary
        7.3.2 Kelun Pharma Business Overview
        7.3.3 Kelun Pharma Parenteral Drugs Major Product Offerings
        7.3.4 Kelun Pharma Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.3.5 Kelun Pharma Key News
    7.4 Cook Pharmica
        7.4.1 Cook Pharmica Corporate Summary
        7.4.2 Cook Pharmica Business Overview
        7.4.3 Cook Pharmica Parenteral Drugs Major Product Offerings
        7.4.4 Cook Pharmica Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.4.5 Cook Pharmica Key News
    7.5 Patheon
        7.5.1 Patheon Corporate Summary
        7.5.2 Patheon Business Overview
        7.5.3 Patheon Parenteral Drugs Major Product Offerings
        7.5.4 Patheon Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.5.5 Patheon Key News
    7.6 BAG Healthcare
        7.6.1 BAG Healthcare Corporate Summary
        7.6.2 BAG Healthcare Business Overview
        7.6.3 BAG Healthcare Parenteral Drugs Major Product Offerings
        7.6.4 BAG Healthcare Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.6.5 BAG Healthcare Key News
    7.7 Beximco Pharma
        7.7.1 Beximco Pharma Corporate Summary
        7.7.2 Beximco Pharma Business Overview
        7.7.3 Beximco Pharma Parenteral Drugs Major Product Offerings
        7.7.4 Beximco Pharma Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.7.5 Beximco Pharma Key News
    7.8 Baxter Healthcare Corporation
        7.8.1 Baxter Healthcare Corporation Corporate Summary
        7.8.2 Baxter Healthcare Corporation Business Overview
        7.8.3 Baxter Healthcare Corporation Parenteral Drugs Major Product Offerings
        7.8.4 Baxter Healthcare Corporation Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.8.5 Baxter Healthcare Corporation Key News
    7.9 B. Braun
        7.9.1 B. Braun Corporate Summary
        7.9.2 B. Braun Business Overview
        7.9.3 B. Braun Parenteral Drugs Major Product Offerings
        7.9.4 B. Braun Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.9.5 B. Braun Key News
    7.10 Fresenius
        7.10.1 Fresenius Corporate Summary
        7.10.2 Fresenius Business Overview
        7.10.3 Fresenius Parenteral Drugs Major Product Offerings
        7.10.4 Fresenius Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.10.5 Fresenius Key News
    7.11 Albert David
        7.11.1 Albert David Corporate Summary
        7.11.2 Albert David Parenteral Drugs Business Overview
        7.11.3 Albert David Parenteral Drugs Major Product Offerings
        7.11.4 Albert David Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.11.5 Albert David Key News
    7.12 BML Parenteral Drugs
        7.12.1 BML Parenteral Drugs Corporate Summary
        7.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview
        7.12.3 BML Parenteral Drugs Parenteral Drugs Major Product Offerings
        7.12.4 BML Parenteral Drugs Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.12.5 BML Parenteral Drugs Key News
    7.13 Pfizer (Hospira)
        7.13.1 Pfizer (Hospira) Corporate Summary
        7.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview
        7.13.3 Pfizer (Hospira) Parenteral Drugs Major Product Offerings
        7.13.4 Pfizer (Hospira) Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.13.5 Pfizer (Hospira) Key News
    7.14 Pisa
        7.14.1 Pisa Corporate Summary
        7.14.2 Pisa Business Overview
        7.14.3 Pisa Parenteral Drugs Major Product Offerings
        7.14.4 Pisa Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.14.5 Pisa Key News
    7.15 Ozon Pharmaceuticals Ltd
        7.15.1 Ozon Pharmaceuticals Ltd Corporate Summary
        7.15.2 Ozon Pharmaceuticals Ltd Business Overview
        7.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Major Product Offerings
        7.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.15.5 Ozon Pharmaceuticals Ltd Key News
    7.16 Aspen Holdings
        7.16.1 Aspen Holdings Corporate Summary
        7.16.2 Aspen Holdings Business Overview
        7.16.3 Aspen Holdings Parenteral Drugs Major Product Offerings
        7.16.4 Aspen Holdings Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.16.5 Aspen Holdings Key News
    7.17 PSI Ltd
        7.17.1 PSI Ltd Corporate Summary
        7.17.2 PSI Ltd Business Overview
        7.17.3 PSI Ltd Parenteral Drugs Major Product Offerings
        7.17.4 PSI Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.17.5 PSI Ltd Key News
    7.18 Wintac Limited
        7.18.1 Wintac Limited Corporate Summary
        7.18.2 Wintac Limited Business Overview
        7.18.3 Wintac Limited Parenteral Drugs Major Product Offerings
        7.18.4 Wintac Limited Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.18.5 Wintac Limited Key News
    7.19 AXA Parenterals Ltd
        7.19.1 AXA Parenterals Ltd Corporate Summary
        7.19.2 AXA Parenterals Ltd Business Overview
        7.19.3 AXA Parenterals Ltd Parenteral Drugs Major Product Offerings
        7.19.4 AXA Parenterals Ltd Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.19.5 AXA Parenterals Ltd Key News
    7.20 Acebright
        7.20.1 Acebright Corporate Summary
        7.20.2 Acebright Business Overview
        7.20.3 Acebright Parenteral Drugs Major Product Offerings
        7.20.4 Acebright Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.20.5 Acebright Key News
    7.21 Southwest Pharmaceutical
        7.21.1 Southwest Pharmaceutical Corporate Summary
        7.21.2 Southwest Pharmaceutical Business Overview
        7.21.3 Southwest Pharmaceutical Parenteral Drugs Major Product Offerings
        7.21.4 Southwest Pharmaceutical Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.21.5 Southwest Pharmaceutical Key News
    7.22 Abbott
        7.22.1 Abbott Corporate Summary
        7.22.2 Abbott Business Overview
        7.22.3 Abbott Parenteral Drugs Major Product Offerings
        7.22.4 Abbott Parenteral Drugs Sales and Revenue in Global (2017-2022)
        7.22.5 Abbott Key News
8 Global Parenteral Drugs Production Capacity, Analysis
    8.1 Global Parenteral Drugs Production Capacity, 2017-2028
    8.2 Parenteral Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Parenteral Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Parenteral Drugs Supply Chain Analysis
    10.1 Parenteral Drugs Industry Value Chain
    10.2 Parenteral Drugs Upstream Market
    10.3 Parenteral Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Parenteral Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
List of Tables
    Table 1. Key Players of Parenteral Drugs in Global Market
    Table 2. Top Parenteral Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Parenteral Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Parenteral Drugs Revenue Share by Companies, 2017-2022
    Table 5. Global Parenteral Drugs Sales by Companies, (K Units), 2017-2022
    Table 6. Global Parenteral Drugs Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Parenteral Drugs Price (2017-2022) & (USD/Unit)
    Table 8. Global Manufacturers Parenteral Drugs Product Type
    Table 9. List of Global Tier 1 Parenteral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Parenteral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Parenteral Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Parenteral Drugs Sales (K Units), 2017-2022
    Table 15. By Type - Global Parenteral Drugs Sales (K Units), 2023-2028
    Table 16. By Application – Global Parenteral Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Parenteral Drugs Sales (K Units), 2017-2022
    Table 20. By Application - Global Parenteral Drugs Sales (K Units), 2023-2028
    Table 21. By Region – Global Parenteral Drugs Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Parenteral Drugs Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Parenteral Drugs Sales (K Units), 2017-2022
    Table 25. By Region - Global Parenteral Drugs Sales (K Units), 2023-2028
    Table 26. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Parenteral Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Parenteral Drugs Sales, (K Units), 2017-2022
    Table 29. By Country - North America Parenteral Drugs Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Parenteral Drugs Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Parenteral Drugs Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Parenteral Drugs Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Parenteral Drugs Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Parenteral Drugs Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Parenteral Drugs Sales, (K Units), 2023-2028
    Table 38. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Parenteral Drugs Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Parenteral Drugs Sales, (K Units), 2017-2022
    Table 41. By Country - South America Parenteral Drugs Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Parenteral Drugs Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Parenteral Drugs Sales, (K Units), 2023-2028
    Table 46. Ostuka Pharmaceutical Corporate Summary
    Table 47. Ostuka Pharmaceutical Parenteral Drugs Product Offerings
    Table 48. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 49. Teva Pharmaceutical Industries Corporate Summary
    Table 50. Teva Pharmaceutical Industries Parenteral Drugs Product Offerings
    Table 51. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 52. Kelun Pharma Corporate Summary
    Table 53. Kelun Pharma Parenteral Drugs Product Offerings
    Table 54. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 55. Cook Pharmica Corporate Summary
    Table 56. Cook Pharmica Parenteral Drugs Product Offerings
    Table 57. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 58. Patheon Corporate Summary
    Table 59. Patheon Parenteral Drugs Product Offerings
    Table 60. Patheon Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 61. BAG Healthcare Corporate Summary
    Table 62. BAG Healthcare Parenteral Drugs Product Offerings
    Table 63. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 64. Beximco Pharma Corporate Summary
    Table 65. Beximco Pharma Parenteral Drugs Product Offerings
    Table 66. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 67. Baxter Healthcare Corporation Corporate Summary
    Table 68. Baxter Healthcare Corporation Parenteral Drugs Product Offerings
    Table 69. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 70. B. Braun Corporate Summary
    Table 71. B. Braun Parenteral Drugs Product Offerings
    Table 72. B. Braun Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 73. Fresenius Corporate Summary
    Table 74. Fresenius Parenteral Drugs Product Offerings
    Table 75. Fresenius Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 76. Albert David Corporate Summary
    Table 77. Albert David Parenteral Drugs Product Offerings
    Table 78. Albert David Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 79. BML Parenteral Drugs Corporate Summary
    Table 80. BML Parenteral Drugs Parenteral Drugs Product Offerings
    Table 81. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 82. Pfizer (Hospira) Corporate Summary
    Table 83. Pfizer (Hospira) Parenteral Drugs Product Offerings
    Table 84. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 85. Pisa Corporate Summary
    Table 86. Pisa Parenteral Drugs Product Offerings
    Table 87. Pisa Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 88. Ozon Pharmaceuticals Ltd Corporate Summary
    Table 89. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Offerings
    Table 90. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 91. Aspen Holdings Corporate Summary
    Table 92. Aspen Holdings Parenteral Drugs Product Offerings
    Table 93. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 94. PSI Ltd Corporate Summary
    Table 95. PSI Ltd Parenteral Drugs Product Offerings
    Table 96. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 97. Wintac Limited Corporate Summary
    Table 98. Wintac Limited Parenteral Drugs Product Offerings
    Table 99. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 100. AXA Parenterals Ltd Corporate Summary
    Table 101. AXA Parenterals Ltd Parenteral Drugs Product Offerings
    Table 102. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 103. Acebright Corporate Summary
    Table 104. Acebright Parenteral Drugs Product Offerings
    Table 105. Acebright Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 106. Southwest Pharmaceutical Corporate Summary
    Table 107. Southwest Pharmaceutical Parenteral Drugs Product Offerings
    Table 108. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 109. Abbott Corporate Summary
    Table 110. Abbott Parenteral Drugs Product Offerings
    Table 111. Abbott Parenteral Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 112. Parenteral Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 113. Global Parenteral Drugs Capacity Market Share of Key Manufacturers, 2020-2022
    Table 114. Global Parenteral Drugs Production by Region, 2017-2022 (K Units)
    Table 115. Global Parenteral Drugs Production by Region, 2023-2028 (K Units)
    Table 116. Parenteral Drugs Market Opportunities & Trends in Global Market
    Table 117. Parenteral Drugs Market Drivers in Global Market
    Table 118. Parenteral Drugs Market Restraints in Global Market
    Table 119. Parenteral Drugs Raw Materials
    Table 120. Parenteral Drugs Raw Materials Suppliers in Global Market
    Table 121. Typical Parenteral Drugs Downstream
    Table 122. Parenteral Drugs Downstream Clients in Global Market
    Table 123. Parenteral Drugs Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Parenteral Drugs Segment by Type
    Figure 2. Parenteral Drugs Segment by Application
    Figure 3. Global Parenteral Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Parenteral Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Parenteral Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. Parenteral Drugs Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Parenteral Drugs Revenue in 2021
    Figure 9. By Type - Global Parenteral Drugs Sales Market Share, 2017-2028
    Figure 10. By Type - Global Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Parenteral Drugs Price (USD/Unit), 2017-2028
    Figure 12. By Application - Global Parenteral Drugs Sales Market Share, 2017-2028
    Figure 13. By Application - Global Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Parenteral Drugs Price (USD/Unit), 2017-2028
    Figure 15. By Region - Global Parenteral Drugs Sales Market Share, 2017-2028
    Figure 16. By Region - Global Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Parenteral Drugs Sales Market Share, 2017-2028
    Figure 19. US Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Parenteral Drugs Sales Market Share, 2017-2028
    Figure 24. Germany Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. France Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Parenteral Drugs Sales Market Share, 2017-2028
    Figure 33. China Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. India Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Parenteral Drugs Sales Market Share, 2017-2028
    Figure 40. Brazil Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Parenteral Drugs Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Parenteral Drugs Sales Market Share, 2017-2028
    Figure 44. Turkey Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Parenteral Drugs Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Parenteral Drugs Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Parenteral Drugs by Region, 2021 VS 2028
    Figure 50. Parenteral Drugs Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
122
Frequently Asked Questions
Parenteral Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parenteral Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parenteral Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports